ArticleScientific reports2025
Clinical significance of the hemoglobin-to-red blood cell distribution width ratio in patients with severe OSAS.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Usefulness of Blood Biomarkers in Screening Patients with Obstructive Sleep Apnea: Could Albumin Indices and Uric Acid-to-HDL Ratio Be New OSAS Severity Indices?Advances in respiratory medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study aimed to evaluate the clinical significance of the hemoglobin-to-red blood cell distribution width ratio (HRR) in patients with severe obstructive sleep apnea syndrome (OSAS). A retrospective analysis was conducted on 216 patients who underwent polysomnography (PSG) between January 2018 and February 2023. Patients were divided into two groups according to the apnea-hypopnea index (AHI): severe OSAS (n = 131) and non-severe OSAS (n = 85). Comparisons were performed between the two groups regarding baseline characteristics, AHI, minimum blood oxygen saturation (MinSaO₂), and hematological parameters including white blood cell (WBC) count, red blood cell (RBC) count, platelet count (PLT), hemoglobin (Hb), red blood cell distribution width (RDW), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and HRR. Correlation analyses were conducted to assess relationships between AHI, MinSaO₂, and HRR in the severe OSAS group. Receiver operating characteristic (ROC) curve analysis revealed that HRR had an area under the curve (AUC) of 0.84 for predicting severe OSAS, with a sensitivity of 81.68%, specificity of 72.94%, and 95% confidence interval (CI) of 0.784-0.886. The levels of AHI, MinSaO₂, Hb, and HRR were significantly higher in the severe OSAS group. Elevated AHI levels may indicate an increased risk of severe OSAS. HRR may serve as an early predictive biomarker for severe OSAS, facilitating timely intervention and potentially reducing complication risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.